- Medtronic buys Xomed for $736mm in stock
- Ethicon buys ENT device maker Acclarent for $785mm in cash
- Start-up ENT device maker Acclarent to go public; withdrawn
- Acclarent closes $26mm Series D after pulling IPO
- Acclarent's Series C brings in $35mm
- Acclarent closes $28mm second round
- Acclarent gets $14.5mm with Series A round
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.